McMahon Gerald PhD 4
4 · Harpoon Therapeutics, Inc. · Filed Sep 6, 2019
Insider Transaction Report
Form 4
McMahon Gerald PhD
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2019-06-05$0.60/sh+169,462$101,677→ 172,462 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-06-05−169,462→ 318,590 totalExercise: $0.60Exp: 2027-01-04→ Common Stock (169,462 underlying)
Footnotes (1)
- [F1]The stock option vested and became exercisable as to 25% of the shares subject to the option on December 19, 2017, and thereafter vested as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.